Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 23298905)

1.

Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway.

Wang J, Kang WM, Yu JC, Liu YQ, Meng QB, Cao ZJ.

Cancer Biol Ther. 2013 Mar;14(3):262-70. doi: 10.4161/cbt.23299. Epub 2013 Jan 8.

2.

TMEM16A overexpression contributes to tumor invasion and poor prognosis of human gastric cancer through TGF-β signaling.

Liu F, Cao QH, Lu DJ, Luo B, Lu XF, Luo RC, Wang XG.

Oncotarget. 2015 May 10;6(13):11585-99.

3.

Association between cadherin-17 expression and pathological characteristics of gastric cancer: a meta-analysis.

Long ZW, Zhou ML, Fu JW, Chu XQ, Wang YN.

World J Gastroenterol. 2015 Mar 28;21(12):3694-705. doi: 10.3748/wjg.v21.i12.3694.

4.

BILL-cadherin/cadherin-17 contributes to the survival of memory B cells.

Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K.

PLoS One. 2015 Jan 22;10(1):e0117566. doi: 10.1371/journal.pone.0117566. eCollection 2015.

5.

Ultrasensitive in vivo detection of primary gastric tumor and lymphatic metastasis using upconversion nanoparticles.

Qiao R, Liu C, Liu M, Hu H, Liu C, Hou Y, Wu K, Lin Y, Liang J, Gao M.

ACS Nano. 2015 Feb 24;9(2):2120-9. doi: 10.1021/nn507433p. Epub 2015 Jan 26.

PMID:
25602117
6.

RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.

Wang S, Lu A, Chen X, Wei L, Ding J.

PLoS One. 2014 Nov 26;9(11):e113891. doi: 10.1371/journal.pone.0113891. eCollection 2014.

7.

Expression of cadherin 17 in well-differentiated neuroendocrine tumours.

Snow AN, Mangray S, Lu S, Clubwala R, Li J, Resnick MB, Yakirevich E.

Histopathology. 2015 Jun;66(7):1010-21. doi: 10.1111/his.12610. Epub 2015 Jan 13.

PMID:
25388236
8.

An RGD motif present in cadherin 17 induces integrin activation and tumor growth.

Bartolomé RA, Peláez-García A, Gomez I, Torres S, Fernandez-Aceñero MJ, Escudero-Paniagua B, Imbaud JI, Casal JI.

J Biol Chem. 2014 Dec 12;289(50):34801-14. doi: 10.1074/jbc.M114.600502. Epub 2014 Oct 21.

PMID:
25336636
9.

WWP1 as a potential tumor oncogene regulates PTEN-Akt signaling pathway in human gastric carcinoma.

Zhang L, Wu Z, Ma Z, Liu H, Wu Y, Zhang Q.

Tumour Biol. 2015 Feb;36(2):787-98. doi: 10.1007/s13277-014-2696-0. Epub 2014 Oct 9.

PMID:
25293520
10.

Novel findings about management of gastric cancer: a summary from 10th IGCC.

Penon D, Cito L, Giordano A.

World J Gastroenterol. 2014 Jul 21;20(27):8986-92. doi: 10.3748/wjg.v20.i27.8986.

11.

RNA interference: a promising therapy for gastric cancer.

Felipe AV, Oliveira J, Chang PY, Moraes AA, da Silva TD, Tucci-Viegas VM, Forones NM.

Asian Pac J Cancer Prev. 2014;15(14):5509-15. Review.

12.

Normal fibroblasts induce E-cadherin loss and increase lymph node metastasis in gastric cancer.

Xu W, Hu X, Chen Z, Zheng X, Zhang C, Wang G, Chen Y, Zhou X, Tang X, Luo L, Xu X, Pan W.

PLoS One. 2014 May 20;9(5):e97306. doi: 10.1371/journal.pone.0097306. eCollection 2014.

13.

PATHOME: an algorithm for accurately detecting differentially expressed subpathways.

Nam S, Chang HR, Kim KT, Kook MC, Hong D, Kwon CH, Jung HR, Park HS, Powis G, Liang H, Park T, Kim YH.

Oncogene. 2014 Oct 9;33(41):4941-51. doi: 10.1038/onc.2014.80. Epub 2014 Mar 31.

14.

Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer.

Lin Z, Zhang C, Zhang M, Xu D, Fang Y, Zhou Z, Chen X, Qin N, Zhang X.

PLoS One. 2014 Jan 20;9(1):e85296. doi: 10.1371/journal.pone.0085296. eCollection 2014.

15.

Overexpression of Bmi-1 induces the malignant transformation of gastric epithelial cells in vitro.

Chen Y, Lian G, Zhang Q, Zeng L, Qian C, Chen S, Huang K.

Oncol Res. 2013;21(1):33-41. doi: 10.3727/096504013X13786659070316.

PMID:
24330850
16.

Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.

Ou JM, Ye B, Qiu MK, Dai YX, Dong Q, Shen J, Dong P, Wang XF, Liu YB, Quan ZW, Fei ZW.

Int J Oncol. 2014 Jan;44(1):276-84. doi: 10.3892/ijo.2013.2171. Epub 2013 Nov 12.

PMID:
24220265
17.

Significance and prognostic value of Gli-1 and Snail/E-cadherin expression in progressive gastric cancer.

Wang ZS, Shen Y, Li X, Zhou CZ, Wen YG, Jin YB, Li JK.

Tumour Biol. 2014 Feb;35(2):1357-63. doi: 10.1007/s13277-013-1185-1. Epub 2013 Oct 1.

PMID:
24081672
18.

VEZT, a novel putative tumor suppressor, suppresses the growth and tumorigenicity of gastric cancer.

Miao R, Guo X, Zhi Q, Shi Y, Li L, Mao X, Zhang L, Li C.

PLoS One. 2013 Sep 17;8(9):e74409. doi: 10.1371/journal.pone.0074409. eCollection 2013.

19.

CRKL promotes cell proliferation in gastric cancer and is negatively regulated by miR-126.

Wang J, Chen X, Li P, Su L, Yu B, Cai Q, Li J, Yu Y, Liu B, Zhu Z.

Chem Biol Interact. 2013 Nov 25;206(2):230-8. doi: 10.1016/j.cbi.2013.09.003. Epub 2013 Sep 18.

PMID:
24055140
20.

Regulation of UHRF1 by miR-146a/b modulates gastric cancer invasion and metastasis.

Zhou L, Zhao X, Han Y, Lu Y, Shang Y, Liu C, Li T, Jin Z, Fan D, Wu K.

FASEB J. 2013 Dec;27(12):4929-39. doi: 10.1096/fj.13-233387. Epub 2013 Aug 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk